Oocyte activation deficiency and assisted oocyte activation: mechanisms, obstacles and prospects for clinical application
<strong>BACKGROUND</strong> Oocyte activation deficiency (OAD) is attributed to the majority of cases underlying failure of ICSI cycles, the standard treatment for male factor infertility. Oocyte activation encompasses a series of concerted events, triggered by sperm-specific phospholipa...
Main Authors: | Kashir, J, Ganesh, D, Jones, C, Coward, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
European Society of Human Reproduction and Embryology
2022
|
Similar Items
-
Oocyte activation deficiency: a role for an oocyte contribution?
by: Yeste, M, et al.
Published: (2015) -
Phospholipase C zeta (PLCζ) and the clinical diagnosis of oocyte activation deficiency
by: Jones, C, et al.
Published: (2022) -
Oocyte activation, phospholipase C zeta and human infertility.
by: Kashir, J, et al.
Published: (2010) -
Oocyte activation and phospholipase C zeta (PLCζ): diagnostic and therapeutic implications for assisted reproductive technology
by: Ramadan Walaa M, et al.
Published: (2012-07-01) -
Oocyte activation and fertilisation: crucial contributors from the sperm and oocyte
by: Yeste, M, et al.
Published: (2017)